Allurion Receives U.S. FDA Approval
Allurion Technologies, Inc. (ALUR)
Company Research
Source: Business Wire
Approval provides Allurion with access to approximately 80 million Americans with obesity NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval (PMA) application for the Allurion Gastric Balloon System, featuring the Allurion Smart Capsule.“Today’s approval is a watershed moment for Allurion and for obesity care in the United States,” said Dr. Shantanu Gaur, Founder and Chief Executive Officer. “Our goal is to deliver patients metabolically healthy weight loss by helping them lose weight, keep it off, and maintain muscle. The Allurion Smart Capsule offers a safe and effective alternative to GLP-1s and bariatric surgery, and it should become a standard tool in the comprehensive treatment of obesity in the United States.”The Allurion Smart Capsule is a state-of-the-art innovation covered by over 50 patents globally. T
Show less
Read more
Impact Snapshot
Event Time:
ALUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALUR alerts
High impacting Allurion Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
ALUR
News
- Allurion Technologies (NYSE:ALUR) was given a new $3.00 price target on by analysts at Loop Capital.MarketBeat
- Allurion Announces Exercise of Warrants for $3.0 Million in Gross ProceedsBusiness Wire
- Allurion Technologies (NYSE:ALUR) was given a new $3.00 price target on by analysts at Chardan Capital.MarketBeat
- Allurion Announces Partnership to Offer Combination Therapy with Mounjaro® (tirzepatide) at Discounted PricesBusiness Wire
- Allurion expects FY25 net sales of 15M [Seeking Alpha]Seeking Alpha
ALUR
Earnings
- 5/14/25 - Beat
ALUR
Sec Filings
- 2/25/26 - Form 8-K
- 2/23/26 - Form 8-K
- 2/17/26 - Form 5
- ALUR's page on the SEC website